4.5 Editorial Material

Epigenetic dysregulation in Alzheimer's disease: cause or consequence?

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

The Role of 5-Hydroxymethylcytosine in Aging and Alzheimer’s Disease: Current Status and Prospects for Future Studies

Daniel L.A. van den Hove et al.

Current Alzheimer Research (2014)

Review Geriatrics & Gerontology

Epigenetically regulated microRNAs in Alzheimer's disease

Daniel L. Van den Hove et al.

NEUROBIOLOGY OF AGING (2014)

Article Cell Biology

Epigenetic changes in the progression of Alzheimer's disease

M. A. Bradley-Whitman et al.

MECHANISMS OF AGEING AND DEVELOPMENT (2013)

Review Clinical Neurology

Epigenetics of Alzheimer's Disease and Frontotemporal Dementia

Chendhore S. Veerappan et al.

NEUROTHERAPEUTICS (2013)

Review Pharmacology & Pharmacy

Epigenetics: A novel therapeutic approach for the treatment of Alzheimer's disease

Lina Adwan et al.

PHARMACOLOGY & THERAPEUTICS (2013)

Article

Midlife vs Late-Life Depressive Symptoms and Risk of Dementia

Kristine Yaffe

ARCHIVES OF GENERAL PSYCHIATRY (2012)

Review Neurosciences

The serotonergic system in ageing and Alzheimer's disease

Jose Julio Rodriguez et al.

PROGRESS IN NEUROBIOLOGY (2012)

Article Clinical Neurology

The pathological process underlying Alzheimer's disease in individuals under thirty

Heiko Braak et al.

ACTA NEUROPATHOLOGICA (2011)

Review Neurosciences

Epigenetic Mechanisms in Cognition

Jeremy J. Day et al.

NEURON (2011)

Article Geriatrics & Gerontology

Epigenetic changes in Alzheimer's disease: Decrements in DNA methylation

Diego Mastroeni et al.

NEUROBIOLOGY OF AGING (2010)

Review Clinical Neurology

Does Alzheimer's disease begin in the brainstem?

G. Simic et al.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2009)

Article Medicine, General & Internal

Global prevalence of dementia: a Delphi consensus study

CP Ferri et al.

LANCET (2005)